https://www.selleckchem.com/products/TW-37.html
9 months vs 7.3 months, p less then 0.05). Moreover, the recurrence rate during the first 6 months was 3.7% in patients who underwent HAL-TURB and 16% in those who received WL-TURB (p less then 0.01). CONCLUSION The results of the study show that recurrence-free survival was longer in patients undergoing HAL-TURB compared to the patients who received standard WL-TURB.INTRODUCTION Penile cancer is rare, accounting for less than 1% of all male cancers in industrialized countries. It is most common in areas of high prevalence of HPV, being a
Like
Comment
Share
